Important Research Use Disclaimer Intended for Research Use Only Retatrutide products are intended exclusively for laboratory research use
According to the National Institutes of Health (NIH- department of the HHS), there is concern for acute pancreatitis and long-term consequences on the thyroid gland with usage of the GLP-1 RA medication
Aaron Shapiro offer GLP-1 weight loss treatments personalized to each patients health profile and goals
To be clear, studies suggest that GLP-1s generally lead to greater and faster weight loss results than relying solely on lifestyle changes like diet and exercise
Common side effects include nausea, vomiting, diarrhoea, and constipation, particularly during the initial titration period
Trujillo JM, Nuffer W, Ellis SL